Product
Pegylated Interferon alfa 2a
1 clinical trial
1 indication
Indication
Chronic Hepatitis BClinical trial
A Phase II of Randomized, Double-blind, Placebo-controlled, Multi-center Study of Hepalatide for Injection Combined With Pegylated Interferon and TAF as Finite Treatment in Chronic Hepatitis B PatientsStatus: Recruiting, Estimated PCD: 2024-08-01